Log in to save to my catalogue

A pathway-driven predictive model of tramadol pharmacogenetics

A pathway-driven predictive model of tramadol pharmacogenetics

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6777452

A pathway-driven predictive model of tramadol pharmacogenetics

About this item

Full title

A pathway-driven predictive model of tramadol pharmacogenetics

Publisher

England: Nature Publishing Group

Journal title

European journal of human genetics : EJHG, 2019-07, Vol.27 (7), p.1143-1156

Language

English

Formats

Publication information

Publisher

England: Nature Publishing Group

More information

Scope and Contents

Contents

Predicting metabolizer phenotype (MP) is typically performed using data from a single gene. Cytochrome p450 family 2 subfamily D polypeptide 6 (CYP2D6) is considered the primary gene for predicting MP in reference to approximately 30% of marketed drugs and endogenous toxins. CYP2D6 predictions have proven clinically effective but also have well-doc...

Alternative Titles

Full title

A pathway-driven predictive model of tramadol pharmacogenetics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6777452

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6777452

Other Identifiers

ISSN

1018-4813

E-ISSN

1476-5438

DOI

10.1038/s41431-019-0369-6

How to access this item